Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2007, p. 4508-4511, Vol. 51, No. 12
0066-4804/07/$08.00+0 doi:10.1128/AAC.00317-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Extensive Genetic Diversity in the Plasmodium falciparum Na+/H+ Exchanger 1 Transporter Protein Implicated in Quinine Resistance
Sumiti Vinayak,1
Mohammad Tauqeer Alam,1
Mala Upadhyay,1
Manoj K. Das,2
Vas Dev,3
Neeru Singh,4
Aditya P. Dash,5 and
Yagya D. Sharma1*
Department of Biotechnology, All India Institute of Medical Sciences, New Delhi,1
National Institute of Malaria Research, Field Station Car Nicobar, Andaman and Nicobar Islands,2
Field Station Sonapur, National Institute of Malaria Research, Assam,3
Field Station Jabalpur, National Institute of Malaria Research, Madhya Pradesh,4
National Institute of Malaria Research, Delhi, India5
Received 7 March 2007/
Returned for modification 22 July 2007/
Accepted 26 September 2007

ABSTRACT
The
Plasmodium falciparum Na
+/H
+ exchanger (
Pfnhe-
1) locus at
chromosome 13 and another locus at chromosome 9 have recently
been proposed to influence quinine resistance. Here, we sequenced
the ms4760 locus of the
Pfnhe-
1 gene from 244
P. falciparum isolates collected from five different regions of India. A total
of 16 different ms4760 alleles (with one to five DNNND repeats)
were observed among these isolates. Interestingly, areas with
a high prevalence of chloroquine and sulfadoxine-pyrimethamine
resistance showed more
Pfnhe-
1 DNNND repeats compared to low
drug resistance areas. The extent of genetic diversity at the
ms4760 locus also varied from one region to another, with expected
heterozygosity values ranging from 0.47 to 0.88.

TEXT
The emergence and spread of resistance in
Plasmodium falciparum against the two most commonly used antimalarial drugs, chloroquine
(CQ) and sulfadoxine-pyrimethamine (SP), has resulted in an
increased use of quinine (QN) (
6,
11). This is because QN is
not only used to treat severe and complicated malaria cases
but is also used to treat patients who do not respond to CQ
and SP treatment. While the genetic basis of CQ and SP resistance
in the parasite is known in great detail (
17), the same is still
evolving for QN resistance (
7,
8). The possible involvement
of the
P. falciparum Na
+/H
+ exchanger (
Pfnhe-
1) membrane transporter
at chromosome 13, along with another locus at chromosome 9,
in QN resistance has recently been proposed (
8,
9). We describe
here the genetic variation in the cytoplasmic domain of the
Pfnhe-
1 protein containing DNNND repeats (ms4760 locus) among
Indian isolates.
The P. falciparum isolates used in this study were collected during 2004 and 2005 from Panna (Madhya Pradesh [MP]; n = 45), Ghaziabad and Aligarh (Uttar Pradesh [UP]; n = 50), Car Nicobar (Andaman and Nicobar [A & N] Islands; n = 55), Kamrup (Assam; n = 74), and Cuttack (Orissa; n = 20) (Fig. 1). Patients attending malaria clinics were screened for the presence of malaria parasites by light microscopy and treated with antimalarial drugs as described earlier (4), in accordance with the national drug policy of India prevalent in the region (http://www.nvbdcp.gov.in). About 200 µl of heparinized blood was collected from P. falciparum-positive individuals. Blood collections were done in accordance with institutional ethical guidelines. Parasite DNA was extracted in accordance with the protocols described earlier (18). An aliquot was used to amplify the ms4760 locus of the Pfnhe-1 gene with primers NHE-A (5'-AGTCGAAGGCGAATCAGATG-3') and NHE-B (5'-GATACTTACGAACATGTTCATG-3') and standard PCR cycling parameters (18). Primers NHE-C (5'-ATCCCTGTTGATATATCGAATG-3') and NHE-D (5'-TTGTCATTAGTACCCTTAGTTG-3') were used for nested PCR. Both strands of the PCR product were sequenced with primers NHE-C and NHE-D by the protocols described earlier (18).
Sequencing of the ms4760 locus of the
nhe-
1 gene from 244
P. falciparum isolates revealed extensive polymorphisms at this
locus (Fig.
2) with an overall calculated heterozygosity (
He)
value of 0.79. The level of genetic variation among the isolates
from UP and MP was relatively lower than that of the isolates
from Assam, Orissa, and the A & N Islands (Table
1). A total
of 16 different ms4760 genotypes of
Pfnhe-
1 were observed among
these isolates. This includes 5 of 8 already reported
Pfnhe-
1 genotypes besides 11 newer genotypes (
8). The frequency of occurrence
of these genotypes varied among the regions (Table
1). Genotypes
ms4760-2, ms4760-4, and ms4760-8, reported by Ferdig et al.
(
8), were not detected among our Indian isolates. Genotypes
ms4760-3 and ms4760-6 were present in all five regions (Table
1). A maximum of 12 genotypes were found in Assam, while UP
had only 3 genotypes.
The number of DNNND repeats varied from one to five, and two
repeats were more common (45.9%,
n = 244) among the isolates
(Fig.
3A). The distribution of isolates with different DNNND
repeats exhibited a regional bias (Fig.
3B). Significantly larger
numbers of isolates from the A & N Islands, Assam, and Orissa
(areas of high CQ and SP resistance) were found to contain a
higher number of DNNND repeats compared to those from UP and
MP (areas with relatively low CQ and SP resistance;
1-
3,
13,
14). However, we have observed that isolates with increased
numbers of DNNND repeats also contained a higher number of mutations
in the
P. falciparum CQ resistance transporter (
P < 0.05)
(data not shown). This indicates that there could be an association
or relationship between the mutations of these two genes. The
exact reason for this geographic variation in
Pfnhe-
1 is not
known and requires further investigation. Earlier, Ferdig et
al. (
8) found a statistically significant association between
the number of DNNND repeats and the level of QN resistance.
Although it may not directly correlate with the clinical outcome,
the number of DNNND repeats may indirectly influence QN responsiveness,
as it can influence the His/Asp ratio of the C-terminal domain
of
Pfnhe-
1 (
7). The His/Asp ratio can affect the cytosolic pH
of the parasite through interactions with other loci and thus
the exchange of Na
+ and H
+ and probably the QN response (
7).
The example shown in the literature is the ms4760-1 genotype-containing
parasite showing a higher level of QN resistance, as this genotype
contains a higher His/Asp ratio (7:4) compared to the QN-sensitive
parasite bearing the genotype ms4760-5 with a His/Asp ratio
of 5:8 (
7,
8). In this context, only 6.5% (
n = 244) of the Indian
isolates contained the ms4760-1 genotype (Table
1). Indeed,
another genotype, ms4760-18, was also found to contain the same
His/Asp ratio, which was present in two isolates only. Thus,
there were a total of 18 (7.38%, total
n = 244) isolates with
a 7:4 His/Asp ratio, which could follow the pattern of QN responsiveness
described by Bennett et al. (
7).
Our findings of more allelic diversity among the isolates from
Assam (12 genotypes,
He = 0.86), Orissa (10 genotypes,
He =
0.88), and the A & N Islands (6 genotypes,
He = 0.70) compared
to the isolates from MP (5 genotypes,
He = 0.47) and UP (3 genotypes,
He = 0.57) are in agreement with reports on the mutations in
the markers associated with other drug resistance in these areas
(
2,
3,
14). Besides, the rates of malaria transmission are also
higher in Assam, Orissa, and the A & N Islands compared
to those in MP and UP (
16). Furthermore, the degree of
He (

0.79)
at the ms4760 locus of the
Pfnhe-
1 gene is also comparable to
the
He observed at other microsatellite loci in
P. falciparum (
5,
12,
18). From a total of 378 nucleotide positions considered
in the alignment, 42 were polymorphic (18 singleton variable
and 24 parsimony informative) and 178 were monomorphic sites.
The haplotype (gene) diversity was 0.90 ± 0.062 (standard
deviation). The nucleotide diversity per site was found to be
0.0515 ± 0.0081, and the nucleotide diversity with Jukes-and-Cantor
correction was 0.054. The minimum number of recombination events
observed was four.
The genetic variations observed in the parasite populations in India may provide useful baseline data for future studies on this promising drug resistance locus. Studies using neutral microsatellite polymorphisms flanking the Pfnhe-1 gene along with other loci in the genome are required to understand the basis of this genetic polymorphism whether it is due to genetic drift or selective pressure.
Nucleotide sequence accession numbers. The nucleotide sequences determined in this study have been assigned accession numbers DQ864466 to DQ864486, EF123065, EF123066, and EF442125 to EF442128.

ACKNOWLEDGMENTS
S.V. and M.T.A. acknowledge the Council of Scientific and Industrial
Research (CSIR) for senior research fellowships. Financial support
for this work granted by the Indian Council of Medical Research
(ICMR) and the Department of Biotechnology (DBT), Government
of India, is acknowledged. We are also grateful to the bioinformatics
facilities of the Biotechnology Information System (BTIS).

FOOTNOTES
* Corresponding author. Mailing address: Department of Biotechnology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. Phone: 91-11-26588145. Fax: 91-11-26589286. E-mail:
ydsharma_aiims{at}yahoo.com 
Published ahead of print on 8 October 2007. 

REFERENCES
1 - Ahmed, A., D. Bararia, S. Vinayak, M. Yameen, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2004. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob. Agents Chemother. 48:879-889.[Abstract/Free Full Text]
2 - Ahmed, A., M. K. Das, V. Dev, M. A. Saifi, Wajihullah, and Y. D. Sharma. 2006. Quadruple mutations in dihydrofolate reductase of Plasmodium falciparum isolates from Car Nicobar Island, India. Antimicrob. Agents Chemother. 50:1546-1549.[Abstract/Free Full Text]
3 - Ahmed, A., V. Lumb, M. K. Das, V. Dev, Wajihullah, and Y. D. Sharma. 2006. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India. Antimicrob. Agents Chemother. 50:3934-3938.[Abstract/Free Full Text]
4 - Alam, M. T., H. Bora, P. K. Bharti, M. A. Saifi, M. K. Das, V. Dev, A. Kumar, N. Singh, A. P. Dash, B. Das, Wajihullah, and Y. D. Sharma. 2007. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents Chemother. 51:857-863.[Abstract/Free Full Text]
5 - Anderson, T. J., X. Z. Su, A. Roddam, and K. P. Day. 2000. Complex mutations in a high proportion of microsatellite loci from the protozoan parasite Plasmodium falciparum. Mol. Ecol. 9:1599-1608.[CrossRef][Medline]
6 - Baird, J. K. 2005. Effectiveness of antimalarial drugs. N. Engl. J. Med. 352:1565-1577.[Free Full Text]
7 - Bennett, T. N., J. Patel, M. T. Ferdig, and P. D. Roepe. 2007. Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance. Mol. Biochem. Parasitol. 153:48-58.[CrossRef][Medline]
8 - Ferdig, M. T., R. A. Cooper, J. Mu, B. Deng, D. A. Joy, X. Z. Su, and T. E. Wellems. 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52:985-997.[CrossRef][Medline]
9 - Gardner, M. J., S. J. Shallom, J. M. Carlton, S. L. Salzberg, V. Nene, A. Shoaibi, A. Ciecko, J. Lynn, M. Rizzo, B. Weaver, B. Jarrahi, M. Brenner, B. Parvizi, L. Tallon, A. Moazzez, D. Granger, C. Fujii, C. Hansen, J. Pederson, T. Feldblyum, J. Peterson, B. Suh, S. Angiuoli, M. Pertea, J. Allen, J. Selengut, O. White, L. M. Cummings, H. O. Smith, M. D. Adams, J. C. Venter, D. J. Carucci, S. L. Hoffman, and C. M. Fraser. 2002. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature 419:531-534.[CrossRef][Medline]
10 - Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
11 - Hyde, J. E. 2005. Drug-resistant malaria. Trends Parasitol. 21:494-498.[CrossRef][Medline]
12 - Leclerc, M. C., P. Durand, T. de Meeus, V. Robert, and F. Renaud. 2002. Genetic diversity and population structure of Plasmodium falciparum isolates from Dakar, Senegal, investigated from microsatellite and antigen determinant loci. Microbes Infect. 4:685-692.[CrossRef][Medline]
13 - Misra, S. P. 1999. In-vivo resistance to chloroquine and sulfa-pyrimethamine combination in Plasmodium falciparum in India. Proc. Natl. Acad. Sci. India 66:123-128.
14 - Mittra, P., S. Vinayak, H. Chandawat, M. K. Das, N. Singh, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2006. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J. Infect. Dis. 193:1304-1312.[CrossRef][Medline]
15 - Rozas, J., J. C. Sanchez-DelBarrio, X. Messeguer, and R. Rozas. 2003. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496-2497.[Abstract/Free Full Text]
16 - Sharma, V. P. 1999. Current scenario of malaria in India. Parasitologia 41:349-353.[Medline]
17 - Valderramos, S. G., and D. A. Fidock. 2006. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27:594-601.[CrossRef][Medline]
18 - Vinayak, S., P. Mittra, and Y. D. Sharma. 2006. Wide variation in microsatellite sequences within each Pfcrt mutant haplotype. Mol. Biochem. Parasitol. 147:101-108.[Medline]
Antimicrobial Agents and Chemotherapy, December 2007, p. 4508-4511, Vol. 51, No. 12
0066-4804/07/$08.00+0 doi:10.1128/AAC.00317-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Henry, M., Briolant, S., Zettor, A., Pelleau, S., Baragatti, M., Baret, E., Mosnier, J., Amalvict, R., Fusai, T., Rogier, C., Pradines, B.
(2009). Plasmodium falciparum Na+/H+ Exchanger 1 Transporter Is Involved in Reduced Susceptibility to Quinine. Antimicrob. Agents Chemother.
53: 1926-1930
[Abstract]
[Full Text]